Article
Cover
RJAS Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 12 Issue No: 1  pISSN: 2249-2194

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Review Article
Rakesh Moolya*,1, Mythrey RC2,

1Rakesh Moolya, Assistant Professor and PhD Scholar SDM College of Ayurveda and Hospital, Hassan, Karnataka, India.

2HOD Government Ayurveda Medical College and Hospital, Mysuru, Karnataka, India.

*Corresponding Author:

Rakesh Moolya, Assistant Professor and PhD Scholar SDM College of Ayurveda and Hospital, Hassan, Karnataka, India., Email: rakeshamoolya@gmail.com
Received Date: 2024-12-06,
Accepted Date: 2025-05-17,
Published Date: 2025-06-30
Year: 2025, Volume: 12, Issue: 1, Page no. 17-21, DOI: 10.26463/rjas.12_1_10
Views: 83, Downloads: 10
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Diabetic peripheral neuropathy (DPN) is the most prevalent consequence of diabetes mellitus (DM). The conventional system's inability to provide adequate therapy causes the disease to worsen, which may result in non-traumatic amputation and neuropathic condition. Purvarupa and Prameha Janya Upadrava are the two broad headings that can be used to compare the symptomatology that corresponds to the clinical presentation of DPN, as it arises due to DM. Vataja nanatmaja vikaras deal with additional lakshanas such as Pada supti and Padaharsha. The concept of Avarana Vata helps in understanding the condition better. If the drug possesses Rasayana property, it will be an added advantage. Shilajatu (Asphalthum punjabianum) is Laghu, Sheeta virya, Katu vipaka and Anamla panchrasa. Its Katu vipaka makes it a Srotosodhaka, which clears the microchannels. With these attributes, Shilajatu aids in dosha pachana (toxic metabolites), eliminates Avrana and aids in Srotoshodhana. It pacifies Vata and prevents the deterioration of nerve tissue. Shilajatu Ojovardhana property assures Dhatu poshana (at the cellular level), which in turn may promote nerve cell regeneration. Further experimental studies have shown presence of fulvic acid in Shilajatu which reduces the risk of degeneration. Further Shilajatu is a Rasayana for Prameha and also a Rasayana for Vata vyadhi. Hence, due to the above qualities, Shilajatu can be used as an ideal therapeutic agent to manage diabetic peripheral neuropathy.

<p>Diabetic peripheral neuropathy (DPN) is the most prevalent consequence of diabetes mellitus (DM). The conventional system's inability to provide adequate therapy causes the disease to worsen, which may result in non-traumatic amputation and neuropathic condition. <em>Purvarupa </em>and <em>Prameha Janya Upadrava</em> are the two broad headings that can be used to compare the symptomatology that corresponds to the clinical presentation of DPN, as it arises due to DM. <em>Vataja nanatmaja vikaras</em> deal with additional <em>lakshanas </em>such as <em>Pada supti</em> and <em>Padaharsha</em>. The concept of <em>Avarana Vata</em> helps in understanding the condition better. If the drug possesses <em>Rasayana </em>property, it will be an added advantage. <em>Shilajatu (Asphalthum punjabianum</em>) is <em>Laghu, Sheeta virya, Katu vipaka</em> and <em>Anamla panchrasa</em>. Its <em>Katu vipaka</em> makes it a <em>Srotosodhaka</em>, which clears the microchannels. With these attributes, <em>Shilajatu </em>aids in <em>dosha pachana</em> (toxic metabolites), eliminates <em>Avrana </em>and aids in <em>Srotoshodhana</em>. It pacifies <em>Vata </em>and prevents the deterioration of nerve tissue. <em>Shilajatu Ojovardhana</em> property assures <em>Dhatu poshana</em> (at the cellular level), which in turn may promote nerve cell regeneration. Further experimental studies have shown presence of fulvic acid in <em>Shilajatu </em>which reduces the risk of degeneration. Further <em>Shilajatu </em>is a <em>Rasayana </em>for <em>Prameha</em> and also a <em>Rasayana </em>for <em>Vata vyadhi</em>. Hence, due to the above qualities, <em>Shilajatu </em>can be used as an ideal therapeutic agent to manage diabetic peripheral neuropathy.</p>
Keywords
Avarana, Diabetic peripheral neuropathy, Prameha, Shilajatu, Vatavyadhi
Downloads
  • 1
    FullTextPDF
Article
Introduction

Neuropathies are among the most prevalent longterm complications of diabetes, affecting up to 50% of patients. Distal symmetrical polyneuropathy (DSPN) is the most common form, accounting for 75% of diabetic neuropathy cases. Diabetic neuropathy (DN) is a frequently occurring disorder, defined as the signs and symptoms of peripheral nerve dysfunction in a patient with diabetes mellitus (DM), where other causes of peripheral nerve dysfunction have been excluded. Diabetic neuropathy is the most common complication of diabetes, with a prevalence of 45-50% compared to 25 30% for retinopathy and 20% for nephropathy. National or population-based studies on diabetic complications are scarce in India. Long-standing peripheral neuropathic pain associated with peripheral neuropathy occurs in one in six people with diabetes. Systematic studies have established that peripheral nerve pathology in diabetic patients is characterised by progressive nerve fibre loss with a pan-modal fibre size pattern. In particular, the nerve fibre degeneration is length dependent and conspicuous in the distal portion. It has recently been shown that tiny fibres are preferentially affected in the early stages of diabetic patients, followed by the involvement of large f ibres related to reduced nerve conduction velocity or decreased vibration threshold.1

Peripheral nervous system cannot be compared to any particular structural component in Ayurveda. However, the Prakruta-Vikrutha Karmas of Vatadosha provide a sufficient explanation for both the healthy and pathological symptoms of the peripheral nervous system, respectively.

Vata in its balanced and unvitiated state controls Chesta or motor and reflex activities and results in Akshanaam patavam, or intact sensory capabilities.2 Vata is Sookshma, Swayambhu and Sarvagata. Although Vata is Avyaktha, Vata karmas  are Vyaktha.3 These qualities of Vata dosha can be compared with that of a nerve impulse. A nerve impulse is invisible, self-originated and self-propagated. Vata dosha functions as a receptor and stimulant. According to Acharya Charaka, without Vata's stimulation, all Dhathus, Malas and Pitta-kapha dosha are incapable of carrying out their functions and might be regarded as Pangu. At the same time, Vata acts as a receptor receiving the stimulation from external environment. A nerve impulse can act as a stimulator and receptor as well. Efferent nerve fibres transmitting impulses from CNS to rest of the body stimulates the muscles to contract and   glands to secrete hormones, while afferent nerve fibres conveying impulses from periphery to CNS act as a receptor for external stimuli like touch, temperature, pressure.

Diabetic Peripheral Neuropathy - Ayurvedic Under standing

Diabetic symptoms can be recognized by characteristics such as, Karapadadaha (burning sensation), Cumcumayana (tingling sensation) and Suptata (numbness), which are observed in Prameha at any point during the disease's Purvarupa (prodromal), Rupa (sign and symptom) or Upadrava (complication stages). Apart from the conditions like Padadaha, Padasupti, Padaharsha, Twak gatavata and Raktaavrita vata, Mamsavrita  lakshanas, Vyanarita vata, Pittavrita prana, Pittavrita vyana, Pittavrita samana, Kapavrita vata coincide well with the symptomatology of diabetic peripheral neuropathy (DPN). DPN is often regarded as Madhumeha janya upadrava for the following reasons:

a)Diabetes mellitus is comparable to Madhumeha due to ‘Madhu sama mootra’ (Glycosuria) and its Asadhyatwam. Hence DPN which is the earliest complication of diabetes mellitus is to be considered as its Upadrava.

b) Vata predominance observed in clinical spectrum of DPN marks its probable  relation to Madhumeha which is a Vataja prameha.

Shilajatu belongs to Maharasa and is a herbo-mineral compound. Shila and Jatu are the two terms that make up the term Shilajatu. Jatu indicates blackish-brown material, while Shila means rock. On hot, sunny days, Shilajatu is an exudation from rocks. India is the first country to emphasize immense medicinal significance of Shilajatu for many centuries BC, even though it may occur in many regions across the world. It states that even Asadhya vyadhi (non-curable illnesses) can be healed by Shodhita Shilajatu following bhavana, which is the addition of drug ingredients in the form of watery extract, etc. According to Dr. H. C. Sen, Shilajatu should be widely used in the treatment of obesity, diabetes, dyspepsia, anasarca, liver and spleen enlargements, bleeding piles, and asthma.

Aim and Objectives

This article critically analyse the effect of Shilajatu on diabetic peripheral neuropathy.

Information regarding DPN and Shilajatu was collected from various classical Ayurvedic text books, articles and research papers from journals.

Shilajatu

Shilajatu has been known to mankind since time immemorial. The detail description of Shilajatu, its sources, method of purification and therapeutic properties are available right from Samhita period. In Charaka Samhita and Sushruta Samhita, Shilajatu is explained in Karaprateechiyam Rasayanapaadam and Chikitsasthana Madhumeha Chikitsa, respectively. In Astanga HrudayaShilajatu is explained in Uttarasthana chapter as Rasayana vidhi.

Types of Shilajatu

There are four types of Shilajatu: Swarna, Rajata, Tamra, Lohaja in Charaka Samhita,Sushruta Samhita,and Astanga Hrudaya has added other two, Naga, Vanga.5,6,7

Importance of Shodhana of Shilajatu

Shodhana means purification. Shilajatu is to be utilized therapeutically, and the contaminants that are accumulated by interaction with metals, dirt, and water must be eliminated.

The main intention and advantages of drug processing are:

1. To purify the drug.

2. To enhance and restore the therapeutic property of drug.

3. To make drug easily digestible, absorbable and adaptable to body.

4. To add properties of drugs intended for specific action by Bhavana, Kshalana Prakshepana.

Indications of Shilajatu

Shilajatu was indicated in various diseases such as Shotha, Pandu, Kshaya, Shwasa, Philavruddhi, Jwara, Agnimaandhya, Apasmara, Unmada, Udara roga, Arshas, Mutrkrichra, Prameha, Ashmari, Kusta, Gulma, Vatarakta.13

Dose / Matra

The dose of Shilajatu can be divided as, Aushadha matra and Rasayana matra.

Aaushada matra

Rasa Tarangini:14 2-8 Ratti (250 mg to 1 g), Rasa chikitsa15 - 2 tola (24 g)

Pathya-apathya

Pathya - Rain water, water from well, water from fountains.16

Apathya - Ahara - Vidhahi, Mamsa, Matsya, Madhya, Guru, Atiamla, more - Guda, salt, oil. Kapota mamsa, Kulattha.17

Vihara - Ativyayama, Atiatapa sevana, Atimaruta sevana, awakening at night time, sleeping in day time, Vegadharana, Stree prasanga, Manasika santapa

Pathya and Apathya should be followed not just during the treatment, but also double the time period preceding the treatment.18

For Meha rogi, Shali anna with Jangala mamsa is advised after the digestion of Shilajatu to prevent from Vataprakopa, as Shilajatu exhibits Shoshana and Chedana properties.

Discussion

Concept of administration of Shilajatu over DPN

Shilajatu (asphaltum) has Madhura-tikta rasa, Laghu yoghavahi guna, Katuvipaka and Ushna veerya. It is Kapha-vatahara having Chedana, Medhohara, Mehahara and Rasayana actions.

Action of Shilajatu in DPN can be explained in two ways

1. Shoshana and Chedana properties of Shilajatu helps in the removal of excessive Medodhatu which is the first Dushya affected in the Samprapti of Medodhatu. Neuropathic features are explained in Prameha purvarupa. In Madhumeha sthanasamshraya of Prakupita, Kapha dosha occurs at Medodhatu level. By the virtue of above said properties of Shilajatu, the Khavaigunya of Medovaha srotas and Dushti in Medodhatu can be corrected. Even in modern science, peripheral resistance due to excessive fat deposition is the first pathology in diabetes mellitus type 2. Shilajatu is proven to be effective in the reduction of lipids as well as in the management of obesity. Neuropathic symptoms are predominantly caused due to Prakupita pitta and Vata. Although the Doshic origin of the disease is Kapha predominant, equal importance should be given for Pitta and Vata doshas for effective management of the condition. Shilajatu with its Madhura tikta rasa pacifies Prakupita pitta and promotes Rakta prasadana. This may be beneficial in treating the burning sensation.

2. Shilajatu is explained as a prime Rasayana dravya in the management of Avruta vata. Guru-sheeta guna, Tikta madhura rasa, Sheeta veerya, etc., may be helpful in removing the Pitta avarana and thus bringing Vatadosha to its normalcy. Thus, the Pitta-vata shamaka property of Shilajatu is effective in correcting the vascular and neurological pathologies involved in DPN.

Shilajatu is a bituminous material made out of a compact mass of vegetable matter with vegeable fibers scattered over a dark, crimson, sticky matrix. Fulvic acid, dibenzo-alpha-pyrones, and dibenzo-alpha-pyrone chromoproteins are the active ingredients in Shilajatu. Pharmacological actions of Shilajatu include, antiaging (promotes the formation of new cells), nutritive (maintain and nourishes cell life), antioxidant, immunomodulatory, anti-inflammatory, and adaptogenic properties.19

Pharmacological actions of Shilajatu20

Anti-inflammatory

Shilajatu has strong anti-inflammatory properties. It had demonstrated a 77% reduction in acute, chemically induced oedema. Additionally, the antioxidant qualities aid in reducing inflammation. When taken orally, Shilajatu (50 mg/kg) significantly reduced inflammation in response to Carrageenan induced pedal oedema.

Analgesic

The antioxidant and anti-inflammatory qualities aid in reducing and relieving joint pain and inflammation. Additionally, the impact on brain’s neurotransmitters appear to alleviate joint discomfort.

For Prameha and Madhumeha (diabetes), it is regarded as the best Naimittika (specific) rasayana. According to Acharya Charaka, Shilajatu has the following qualities: Kashaya (astringent), Tikta (bitter) rasa (taste), Sheeta virya (cold potency), Vrishya (aphrodisiac), Balya (strength promoting), Mutrala (diuretic), Lekhana (scraping), Yogavahi (bio-availability enhancer) and Rasayana properties. Shilajatu has been shown to have antioxidant  properties. Resonance stabilized soft-spin semiquinone free radicals which make up processed Shilajatu, have been demonstrated to have antioxidant and free radical scavenging properties against SO3- and OH radicals, as well as paramagnetic nitric oxide (NO). Additionally, it has been reported that Andean Shilajatu in Chile has demonstrated an Oxygen Radical Absorbance Capacity (ORAC) index of 50 to 500 Trolox units/g of material, which is significantly greater than that of noni and blueberries. Shilajatu appears to be a potent antioxidant phyto-complex in this regard. Shilajtu possesses anti-inflammatory qualities according to a study. It has been demonstrated that Shilajatu can lessen inflammation caused by Carrageenan in rats, including granuloma pouch and pedal oedema. It has strong nootropic and antioxidant properties. Charaka Samhita recommends Shilajatu as a cure for almost every human ailment. Its active  ingredients quickly neutralizes toxins, restores electrical balance and regenerates cells, while delaying the deterioration of vital nutrients.

Conclusion

Shilajatu, as described in classical Ayurvedic literature and substantiated by modern research, plays a significant role in the management of Madhumeha due to its multifaceted pharmacological actions. Its Rasayana and Lekhana properties help rejuvenate Dhatus and reduce excessive Meda (fat). Shilajatu possesses the ability to eliminate Avarana, has Srotoshodana, Rasayana properties, and is rich in antioxidants, anti-inflammatory agents, immunomodulatory, chelating compounds, and memory-enhancing properties, and fluvic acid. These qualities help in promoting nerve cell regeneration and reduce the risk of degeneration. Thus it is beneficial in managing diabetic peripheral neuropathy.

Conflict of Interest

There are no conflicts of interest

Supporting File
References
  1. Rakesh, Mythrey RC. Ayurvedic understanding of the etiopathogenesis of diabetic peripheral neuropathy. International Ayurvedic Medical Journal 2025;589-595.
  2. Vagbhata, Sreekumar T. Ashtanga Hridaya. Sreekumar T, translator.   Mannuthy: Harisree Hospital Publication Department; 2011. p. 266.
  3. Susruta DG. Susruta Samhita. Vaidya Yadavji Tri kamji Acharya and Narayan Ram Acharya kavyatirtha, editors. Varanasi: Chaukhamba Sanskrit Sansthan; 2013. p. 258.
  4. Ravi PR, Singh AK, Gaurav. Shilajatu an unique drug in Ayurveda - A literary review. World Journal of Pharmacy and Pharmaceutical Sciences 2017;6(10):517-540.
  5. Agnivesha. Charaka Samhita revised by Charaka and Dridhabala with Vaidhyamanorama Hindi commentary. Editor Acharya Shukla Vidhyadhar, Prof. Tripathi Ravidutta. Vol 2, Chiktsasthana. Delhi: Chaukhambha Sanskrit Pratisthan; Reprint 2010. p. 34.
  6. Susrutha. Susruthasamhita with Susruthavimarshini Hindi commentary. Editor Dr. Sharma Anant Ram. Vol 2, Chiktsasthana. Varanasi: Chaukhambha Surbharati Prakashan; Reprint 2010. p. 278-280. 
  7. Srimadvagbhata. Astanga Hrudaya with Nirmala Hindi commentary. Dr. Tripathi Brahmanand. Uttarasthana. Delhi: Chaukhambha Sanskrit Prat isthan; Reprint 2011. p. 1198-1200.
  8. Sharma S. Rasatarangini. Editor Shastri Kashinath. 11th ed. 22nd Chapter. New Delhi: Motilal Banarasi Das; 1979. p. 583-84.
  9. Acharya Rasa Vagbhat. Rasaratna Samuchaya. Edi tor Mishra Siddhi Nandan. Edited with Siddhi Prada Hindi Commentary. 1st ed. 2nd Chapter. Varanasi: Chaukhamba Orientalia; 2011. p. 49.
  10. Acharya Sri Madhava. Ayurveda Prakasha with Arthavidyotini and Arthaprakashini Sanskrit and Hindi commentaries. Translator Mishra Gulrajsharma. 4th ed. 2nd Chapter. Varanasi: Chaukhamba Bharati Academy; 1994. p. 431. 
  11. Shree Manthana Bhairava. Anandakandah. Translator Mishra Siddhi Nanadan. Siddhiprada Hindi Commentary. 1st ed. Kriyakarana Dwitiyavishranti. 1st Chapter. Varanasi: Chaukhambha Orientalia; 2008. p. 668.
  12. Sharma S. Rasatarangini. Editor Shastri Kashinath. 11th ed. 22nd Chapter. New Delhi: Motilala Banarasi Das; 1979. p. 587.
  13. Sharma S. Rasatarangini. Editor Shastri Kashinath. 11th ed. 22nd Chapter. New Delhi: Motilala Banarasi Das; 1979. p. 588.
  14. Sharma S. Rasatarangini. Editor Shastri Kashinath. 11th ed. 22nd Chapter. New Delhi: Motilala Banarasi Das; 1979. p. 591.
  15. Chatterji Kaviraj Prabhakar. Rasa Chikitsa. 2nd ed. Varanasi: Chaukhamba Bharati Academy; 1996. p. 33. 
  16. Chatterji Kaviraj Prabhakar. Rasa Chikitsa. 2nd ed. Varanasi: Chaukhamba Bharati Academy; 1996. p. 34. 
  17. Anonymous. Rasa Tantra Sara Siddha Prayoga Samgraha. 15th ed. Rajasthan: Srikrishna Gopal Ayurveda Bhavan; 2001. p. 34.
  18. Susrutha. Susruthasamhita with Susruthavimarshini Hindi Commentary. Editor Dr. Sharma Anant Ram. Vol 2. Chiktsasthana. Varanasi: Chaukhambha Surbharati Prakashan; Reprint 2010. p. 279.
  19. Singh R, Kaushik S, Yadav P, et al. Research developments in immunomodulatory and antioxidant activities of Shilajatu. Indian Durgs 2021;58(9):7-20.
  20. Chaudhary SP, Singh AK, Dwivedi KN. Medicinal properties of shilajit a review. Indian Journal of Agriculture and Allied Science 2016;2(1);103-10.
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.